Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    - Revision tag updated from v3.6.3 to v3.6.4 on the page, indicating a backend/template update.
    Difference
    0.1%
    Check dated 2026-07-25T18:35:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    No changes were detected between the compared page versions; the study details content appears unchanged.
    Difference
    0.1%
    Check dated 2026-07-18T16:55:09.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a minor platform/template update. This change does not alter the trial details or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-04T09:21:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added to the page, replacing Revision: v3.6.0. This change represents a version update with no impact on the study content or user interactions.
    Difference
    0.1%
    Check dated 2026-06-27T05:38:27.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    No textual changes are reflected in the available data. The study details page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-06-20T03:22:53.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The study details page adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a version stamp (Revision: v3.6.0). The legacy labels and the formatting of the contact line were removed or adjusted (e.g., Last known status, the Daniela Katz M.D. line).
    Difference
    2%
    Check dated 2026-06-12T23:49:11.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.